GSK Share Holder Equity 2010-2022 | GSK

GSK share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
  • GSK share holder equity for the quarter ending June 30, 2022 was $28.425B, a 5.76% decline year-over-year.
  • GSK share holder equity for 2021 was $29.347B, a 9.84% increase from 2020.
  • GSK share holder equity for 2020 was $26.717B, a 13.98% increase from 2019.
  • GSK share holder equity for 2019 was $23.44B, a 378.23% increase from 2018.
GSK Annual Share Holder Equity
(Millions of US $)
2021 $29,347
2020 $26,717
2019 $23,440
2018 $4,901
2017 $4,497
2016 $6,726
2015 $13,574
2014 $8,135
2013 $12,224
2012 $10,695
2011 $14,162
2010 $15,069
2009 $15,667
GSK Quarterly Share Holder Equity
(Millions of US $)
2022-06-30 $28,425
2022-03-31 $30,368
2021-12-31 $29,347
2021-09-30 $29,988
2021-06-30 $30,162
2021-03-31 $28,973
2020-12-31 $26,717
2020-09-30 $26,643
2020-06-30 $24,988
2020-03-31 $25,744
2019-12-31 $23,440
2019-09-30 $22,270
2019-06-30 $3,815
2019-03-31 $4,391
2018-12-31 $4,901
2018-09-30 $4,851
2018-06-30 $4,114
2018-03-31 $4,996
2017-12-31 $4,497
2017-09-30 $6,322
2017-06-30 $5,657
2017-03-31 $6,928
2016-09-30 $5,251
2016-06-30 $6,064
2016-03-31 $9,372
2015-12-31 $13,574
2015-09-30 $14,468
2015-06-30 $16,161
2015-03-31 $17,296
2014-12-31 $8,135
2014-09-30 $9,608
2014-06-30 $11,505
2014-03-31 $12,300
2013-12-31 $12,224
2013-09-30 $10,542
2013-06-30 $11,170
2013-03-31 $11,835
2012-12-31 $10,695
2012-09-30 $11,104
2012-06-30 $12,346
2012-03-31 $15,044
2011-12-31 $14,162
2011-09-30 $13,268
2011-06-30 $15,398
2011-03-31 $15,829
2010-12-31 $15,069
2010-09-30 $16,448
2010-06-30 $14,239
2010-03-31 $17,841
2009-12-31 $15,667
2009-09-30 $15,234
2009-06-30 $11,947
2009-03-31 $11,593
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $61.844B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $152.564B 9.26
Bio-Rad Laboratories (BIO.B) United States $13.545B 29.93
QIAGEN (QGEN) Netherlands $9.898B 16.57
Ginkgo Bioworks Holdings (DNA) United States $5.908B 0.00
Myovant Sciences (MYOV) United Kingdom $2.391B 0.00
Arcus Biosciences (RCUS) United States $2.007B 39.18
Emergent Biosolutions (EBS) United States $1.039B 6.02
Biohaven Pharmaceutical Holding (BHVN) United States $0.878B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.392B 0.00
Zymeworks (ZYME) Canada $0.354B 0.00
Enzo Biochem (ENZ) United States $0.113B 0.00
Gelesis Holdings (GLS) United States $0.087B 0.00
SQZ Biotechnologies (SQZ) United States $0.075B 0.00
Ambrx Biopharma (AMAM) United States $0.045B 0.00